Evaluation of Pancreatic Cystic Lesions Via EUS-guided Fine Needle Aspiration With and Without Micro Forceps Biopsies
Launched by UNIVERSITY OF COLORADO, DENVER · May 21, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to evaluate pancreatic cystic lesions (PCLs), which are fluid-filled sacs in the pancreas that can sometimes be found during imaging tests like CT or MRI scans. The study is comparing two methods of collecting samples from these cysts using a procedure called endoscopic ultrasound (EUS). One method is the traditional fine needle aspiration (EUS-FNA), which collects fluid from the cyst, while the other method includes a newer technique using micro forceps that can take a small piece of the cyst wall for further examination. The goal is to see if the newer method can provide better information about the cysts, helping doctors determine if they are potentially harmful.
To participate in this trial, you would need to be an adult over 18 years old with a pancreatic cyst that is larger than 20 millimeters and appropriate for sampling. The study is open to all genders, but certain conditions, like bleeding disorders or being pregnant, would make you ineligible. If you join the trial, you can expect to undergo the EUS procedure, where your doctor will collect samples to help clarify the nature of the cyst. This research could improve how doctors diagnose and manage pancreatic cysts, potentially changing treatment approaches in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients \>18 years old
- • Cysts \> 20 mm in size deemed appropriate for FNA by the endoscopist, based on clinical presentation, radiologic imaging features, associated solid mass or nodules, and patient anxiety about the diagnosis
- Exclusion Criteria:
- • Age \<18 years
- • Inability to provide informed consent
- • Thrombocytopenia (Platelets \< 50,000) or coagulopathy (INR \> 1.8)
- • Pregnancy
- • Post-surgical anatomy where the cyst is not accessible for FNA
- • EUS findings suggesting that cyst FNA would be unsafe (e.g. intervening blood vessels)
- • EUS appearance suggesting FNA is not indicated (e.g. cyst smaller than prior radiologic imaging, cyst not seen, EUS suggestive of serous cystadenoma)
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Irvine, California, United States
New York, New York, United States
Aurora, Colorado, United States
Patients applied
Trial Officials
Anna Duloy, MD
Principal Investigator
University of Colorado, Denver
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials